On February 2 The HPRA carried out a five time on-site inspection which commenced.

That is further evidence of our continued dedication to global GMP compliance.’ mentioned Elaine Sapinoso, Vice President of Quality and Regulatory of Althea. ‘These accomplishments validate the hard work and investments we have made through the years to maintain our quality systems at a level that meets current regulatory goals. We take pride in offering quality providers to our clients while ultimately ensuring basic safety of the patients receiving these new drugs.’.. Althea obtains European GMP certificate from HPRA for business aseptic screening and filling Ajinomoto Althea, Inc. , a leading provider of biopharmaceutical contract development and manufacturing providers announced today that it offers officially received its European GMP certificate from the Health Products Regulatory Authority for commercial aseptic filling and testing.Our science indicated that bisphenol-A could be harmful to both human health insurance and the environment and we had been the first country to take bold actions in the curiosity of Canadians, said Canadian Health Minister Leona Aglukkaq in a statement back in 2010. However in typical wishy-washy style, these same corporate-backed bureaucrats are now back-peddling by trying to declare that BPA is just fine, for infants and babies even. In full denial of copious levels of proof showing that actually low levels of publicity to BPA could cause organ harm, developmental disorders, reproductive infertility and damage, digestive dysfunction, DNA harm, endocrine disruption and several other conditions, Wellness Canada is wanting to pull the wool over the eye of the public by blatantly kowtowing to the chemical substance market.